Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.65    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.05 (1.075%)
Market Cap: £223.18m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

DSS trial with Cliffs Natural Resources

25 Oct 2013 13:08

RNS Number : 4427R
Seeing Machines Limited
25 October 2013
 



Seeing Machines Limited

("Seeing Machines" or the "Company")

 

 

Seeing Machines' operator safety division announces DSS trial with Cliffs Natural Resources

 

Canberra, Australia, 25 October 2013: Seeing Machines, (AIM: SEE), announces today that the operator safety division has received purchase orders from Cliffs Natural Resources Inc. ("Cliffs") to commence a trial of its Driver State System ("DSS") fatigue and distraction monitoring solution at their Koolyanobbing operations in the Yilgarn Region, Western Australia.

 

The technology will be installed into 6 road trains for a 90 day fatigue assessment trial which, once completed, could see a larger scale rollout across the fleet. The value of this deployment is over AUD$150,000. Cliffs has iron ore and coal mines in North America as well as the iron ore mining complex in Western Australia, and always operates under a framework of strong core values of which Safe Production plays a pivotal role.

 

Ken Kroeger, Seeing Machines' CEO, said:

 

"We are delighted to be working with Cliffs Natural Resources and launching another trial with such a great global company. There are not very many companies in the world with such impressive mine and transport logistics portfolios. We believe that the DSS technology is a great fit, as their 160 year business history is underpinned by core values that take safe production very seriously. Cliffs made their selection through a process that evaluated our computer vision based technology against competitive products that require the operator to always wear some form of sensor."

 

About Seeing Machines' driver safety division and DSS

 

Seeing Machines creates face and eye tracking technology for diverse industry sectors and applications. DSS, the driver safety division's mining solution, keeps equipment operators safe by detecting episodes of drowsiness and lapses in concentration. DSS sends real-time alerts to both driver and dispatch, supporting ongoing risk reduction through early intervention and promotion of safe work practice. For more information please go to www.dssmining.com

 

Enquiries:

www.seeingmachines.com

Seeing Machines Limited

Ken Kroeger, Managing Director and CEO

+61 2 6103 4700

Ken.Kroeger@seeingmachines.com

James Walker, Chief Financial Officer

+61 2 6103 4700

James.Walker@seeingmachines.com

 

Terry Winters, Chairman

+61 2 6103 4700

Terry.Winters@seeingmachines.com

 

finnCap Limited

Ed Frisby / Ben Thompson, Corporate Finance +44 20 7220 0500

Simon Starr, Corporate Broking

 

AxiCom Limited

James Kennedy +44 20 8392 4091

James.kennedy@axicom.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGGQUUUPWGPA
Date   Source Headline
12th May 20267:00 amRNSUS$3.8m Order for Guardian BdMS
6th May 20267:00 amRNSQ3 FY2026 Quarterly KPIs
20th Apr 202612:30 pmRNSHolding(s) in Company
10th Apr 20268:53 amRNSStatement re alleged cyber threat
27th Mar 20267:00 amRNSHalf-year Financial Report
24th Feb 20267:00 amRNS-RPublication of Investor Presentation
18th Feb 20267:00 amRNSTrading Update - H1 FY2026
13th Feb 20267:30 amRNSAppointment of Joint Broker
11th Feb 20267:00 amRNSQ2 FY2026 Quarterly KPIs
13th Jan 202612:00 pmRNS-R3D Cabin Perception Mapping breaks new ground
6th Jan 20267:00 amRNSAgreement
5th Jan 20267:00 amRNSHolding(s) in Company
5th Jan 20267:00 amRNS-R3D Cabin Perception Mapping to be unveiled at CES
2nd Jan 20267:00 amRNS-RSeeing Machines Announces Future Mobility Group
2nd Jan 20267:00 amRNS-RSeeing Machines Announces Future Mobility Group
17th Dec 20257:00 amRNS-RTechnical Paper Series - Intoxication launched
4th Dec 20257:00 amRNS-RSeeing Machines 2025 Guardian Insights Report
27th Nov 20257:00 amRNSResults of AGM
26th Nov 20257:30 amRNSJapanese Auto Award and Extended European Program
12th Nov 20257:05 amRNSQ1 FY2026 Quarterly KPIs
12th Nov 20257:00 amRNSGuardian order from US-based multinational company
6th Nov 20257:05 amRNS-RCollaboration with Magna milestone in China
3rd Nov 20257:00 amRNSBoard Changes
3rd Nov 20257:00 amRNSNotice of Annual General Meeting
30th Oct 20257:00 amRNSLATAM Distributor Orders 1,300 Guardian Units
29th Oct 20257:00 amRNSAdvanced Development Project with Japanese OEM
8th Oct 20257:00 amRNSUS$1.8m expansion order for Guardian BdMS
26th Sep 20257:00 amRNSExpanding Guardian prospects across Europe
25th Sep 20257:00 amRNSFY2025 Results and Annual Financial Report
24th Sep 20257:20 amRNSFirst Guardian contract through Mitsubishi
10th Sep 20257:05 amRNS-RSeeing Machines Launches Impairment Capability
10th Sep 20257:00 amRNSNotice of Results and Presentation
29th Aug 202510:10 amRNSDirector Dealing
21st Aug 20257:00 amRNSFY2025 Trading Update
5th Aug 20257:00 amRNSQ4 FY2025 Quarterly KPIs
30th Jun 20257:00 amRNSMitsubishi Electric Europe Guardian collaboration
27th Jun 20257:00 amRNSUS Guardian Gen 3 trial with Mitsubishi Electric
16th Jun 20258:59 amRNS$1.2 Million Agreement with Global Auto Leader
9th May 20252:31 pmRNSDirector dealing
1st May 20257:00 amRNSQ3 FY2025 Quarterly KPIs
29th Apr 20259:58 amRNSNotification of Major Holdings
8th Apr 20258:53 amRNSHoldings in Company
8th Apr 20257:00 amRNSDirector/PDMR Shareholding
4th Apr 20257:00 amRNSDirector dealing
2nd Apr 202511:00 amRNSLondon presentation for investors and analysts
2nd Apr 20257:00 amRNSDirector dealing
2nd Apr 20257:00 amRNSDirector dealing
1st Apr 202512:00 pmRNS-RSeeing Machines Announces 3D Camera Technology
31st Mar 20257:00 amRNSDirector/PDMR Shareholding
28th Mar 20257:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.